Status: Not yet recruiting
Trial of NASHA Dx Urethral Bulking System
Prospective, randomized, single-blind study to evaluate the safety and efficacy of NASHA Dx investigational device compared to controlled device Bulkamid in adult women with mild, moderate and intrinsic sphincter deficiency (ISD).
Participants needed: 314
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Palette Life Sciences, Inc.Updated: Sep 30, 2026Locations: 5
Eligibility criteria
1. Female, ≥ 18 years of age [+11]
1. Urgency Predominant Mixed urinary incontinence, confirmed by 3-day bladder di... [+29]